The ‘world’s first study on an AI-based diagnostic system in acute medicine’ failed to meet the high expectations of researchers, the Bern Inselspital announced on Monday.
According to a study published in the journal The Lancet Digital Health, the system showed no measurable advantage over conventional diagnostic methods.
For the study, the researchers examined the diagnoses of around 1,200 patients who were treated with non-specific complaints in four Swiss emergency departments. The researchers used the AI-based Isabel Pro system to help diagnose some of the patients.
In both groups, 18% of patients showed quality problems in the diagnoses over a two week period.
More
More
How do you build trust in new technologies?
This content was published on
Could the “Swiss Digital Trust Label” be the solution for encouraging the responsible use of new technologies?
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
Swiss study: Arabica cultivation areas could be halved by 2050
This content was published on
Around the world, the areas most suitable for growing the bean could even shrink by 60% if greenhouse gas emissions remain high.
This content was published on
The UN Human Rights Council approved the launch of this mechanism in Geneva on Friday, to be followed by an International Commission of Inquiry.
More than 100 wolves shot in Switzerland last year
This content was published on
Swiss hunters legally killed 101 wolves between February 1, 2024, and the end of January 2025. A further six died in accidents or from natural causes.
Swiss health office turns to Bluesky against backdrop of US censorship
This content was published on
The Swiss Federal Office of Public Health (FOPH) has joined the Bluesky social network, while US President Donald Trump works with X owner Elon Musk to censor content on official US websites.
Biotech company BioVersys is first Swiss IPO of 2025
This content was published on
The Basel-based biotech company BioVersys made the first initial public offering (IPO) of the year in Switzerland on Friday.
Much more spent on Swiss motorway vote campaigns than budgeted
This content was published on
Opponents and supporters of motorway expansion spent over CHF10 million ($11 million) on their campaigns, around a third more than announced in November.
Swiss researchers monitor animal populations with AI microphone
This content was published on
Researchers in Lausanne are using an intelligent microphone to make the animal world audible. The microphone automatically records animal sounds over large areas and analyses them using AI.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.